These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3732486)

  • 21. Photochemical decomposition of phenazone derivatives. Part 6: Effect of substituents on mass fragmentation and photochemical stability.
    Marciniec B
    Pharmazie; 1985 Feb; 40(2):110-2. PubMed ID: 4001143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the behavior and metabolism of pharmaceutical residues during purification of contaminated ground water used for drinking water supply.
    Zuehlke S; Duennbier U; Heberer T
    Chemosphere; 2007 Nov; 69(11):1673-80. PubMed ID: 17662339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies of the mechanism of enzyme induction. XIV. Effect of age on the activity and inducibility of phenazone hydroxylases, aminophenazone-N-demethylase, codeine-O-demethylase and nitroreductase of the rat liver].
    Klinger W; Kusch T; Neugebauer A; Splinter FK; Ankermann H
    Acta Biol Med Ger; 1968; 21(3):257-69. PubMed ID: 5750773
    [No Abstract]   [Full Text] [Related]  

  • 24. Topical provocation of fixed drug eruption.
    Alanko K; Stubb S; Reitamo S
    Br J Dermatol; 1987 Apr; 116(4):561-7. PubMed ID: 2953388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The specificity of the lymphocyte transformation test in a patient with hypersensitivity reactions to pyrazolone compounds. A 10-week follow-up study before and after rechallenge.
    Brattig NW; Diao GJ; Berg PA
    Eur J Clin Pharmacol; 1988; 35(1):39-45. PubMed ID: 3265385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-resolution MS and MS(n) investigation of ozone oxidation products from phenazone-type pharmaceuticals and metabolites.
    Favier M; Dewil R; Van Eyck K; Van Schepdael A; Cabooter D
    Chemosphere; 2015 Oct; 136():32-41. PubMed ID: 25935697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gas chromatographic determination of phenazone derivatives in human plasma. II. Propyphenazone.
    Sioufi A; Marfil F
    J Chromatogr; 1978 Nov; 146(3):508-17. PubMed ID: 721928
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacological actions of a salt of aminophenazone: cyclohexylsulfamate of 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone. I. Toxicity and analgesic activity].
    Mucci P; Bertolini A; Sternieri E
    Boll Soc Ital Biol Sper; 1965 Mar; 41(5):235-9. PubMed ID: 5876877
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute toxicity of substrates of the mixed function oxidase system in normal and phenobarbital-pretreated mice.
    Litterst CL; Mimnaugh EG; Gram TE; Guarino AM; Simon RC
    J Toxicol Environ Health; 1975 Sep; 1(1):39-46. PubMed ID: 810600
    [No Abstract]   [Full Text] [Related]  

  • 30. [EXPERIMENTAL AND CLINICAL OBSERVATIONS ON THE PHENAZONE-AMINOPHENAZONE MOLECULAR ASSOCIATION].
    DEMARTIIS M; GIULIANI A; SAMMARTINO V
    Clin Ter; 1964 Jan; 28():37-50. PubMed ID: 14126097
    [No Abstract]   [Full Text] [Related]  

  • 31. Ultrastructural changes in the liver of aminophenazone- and nitrite-intoxicated rats.
    Crăciun C; Rusu MA
    Morphol Embryol (Bucur); 1980; 26(2):163-6. PubMed ID: 6446033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of pharmacologic effects of aminophenazone and isopropylphenazone (proceedings)].
    Grupe R; Rösner G; Morgenstern E
    Pharmazie; 1979; 34(5-6):367-9. PubMed ID: 515159
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative experimental investigations on isopropylphenazone and aminophenazone.
    Marmo E; Vacca C; Lampa E; Giordano L; Ottavo R; Rosatti F; Ariello B; Visone C; Cantone F; Rossi F; Giasi M; Perna D; Imperatore A
    Farmaco Prat; 1980 Dec; 35(12):581-619. PubMed ID: 6970681
    [No Abstract]   [Full Text] [Related]  

  • 34. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone.
    Himly M; Jahn-Schmid B; Pittertschatscher K; Bohle B; Grubmayr K; Ferreira F; Ebner H; Ebner C
    J Allergy Clin Immunol; 2003 Apr; 111(4):882-8. PubMed ID: 12704373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Quantitative thin-layer chromatographic estimation of aminophenazone (I.N.N.), 4-methylaminophenazone and 4-aminophenazone in plasma (author's transl)].
    Hüller G; Haustein KO
    Pharmazie; 1981 Aug; 36(8):546-8. PubMed ID: 7291286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute toxicity of pyrazolones.
    Okonek S; Reinecke HJ
    Am J Med; 1983 Nov; 75(5A):94-8. PubMed ID: 6359872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Availability of propylphenazone from suppositories. 2. Bioavailability].
    Hackenberger F; Gabrio T; Grune D; Bornschein M; Dietzsch B; Voigt R
    Pharmazie; 1986 Apr; 41(4):244-7. PubMed ID: 3725865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further production and characterization of antibodies reactive with pyrazolone derivatives.
    Takatori T; Yamaoka A
    J Immunol Methods; 1980; 35(1-2):147-55. PubMed ID: 7204986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Toxicity of propyphenazone].
    von Mühlendahl KE; Kahn D; Krienke EG
    Dtsch Med Wochenschr; 1978 Sep; 103(38):1490-1. PubMed ID: 688883
    [No Abstract]   [Full Text] [Related]  

  • 40. Daily rhythmic variation in hepatic amidopyrine-N-demethylation, hexobarbital sleeping time and acetanilide and phenazone toxicity in rats of different age.
    Becher H; Schnupp P; Klinger W
    Z Versuchstierkd; 1975; 17(5-6):256-62. PubMed ID: 1210817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.